Dissemin is shutting down on January 1st, 2025

Published in

National Academy of Sciences, Proceedings of the National Academy of Sciences, 39(113), p. 10992-10997, 2016

DOI: 10.1073/pnas.1605265113

Links

Tools

Export citation

Search in Google Scholar

Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Significance Dystroglycan (DG) is an extracellular matrix receptor that is linked to the cytoskeleton and critical for the development of skeletal muscle. DG deficiency throughout development is associated with multiple pathological features and muscular dystrophy. However, the direct consequence of DG disruption in mature muscle is not known. Here, we investigate muscles of transgenic mice after genetic knockdown of DG at maturity. The results demonstrate early susceptibility to contraction-induced injury accompanied by reduced passive tension and decreased titin immunostaining, rather than increased necrosis, excitation–contraction uncoupling, or sarcolemmal fragility. These results suggest a need for critical rethinking of both current theories regarding contraction-induced injury in muscular dystrophy and therapeutic strategies.